PriceTargets.com logo

1Life Healthcare - ONEM Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$16.47 As of 02/22/2023 01:00 AM ET
+0 (0.00%)
Get New 1Life Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ONEM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ONEM

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for 1Life Healthcare in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $16.47.

This chart shows the closing price for ONEM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in 1Life Healthcare. This rating has held steady since October 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/30/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/28/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/27/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral$18.00
8/15/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$12.00 ➝ $18.00
8/9/2022Evercore ISIBoost Target$18.00
7/27/2022Stifel NicolausDowngradeBuy ➝ Hold
7/25/2022Truist FinancialDowngradeBuy ➝ Hold$18.00
7/22/2022Piper SandlerBoost Target$18.00
7/22/2022Leerink PartnersBoost TargetMarket Perform$9.00 ➝ $18.00
7/22/2022BTIG ResearchDowngradeBuy ➝ Neutral
7/22/2022CitigroupDowngradeBuy ➝ Neutral$14.00 ➝ $18.00
7/22/2022Deutsche Bank AktiengesellschaftBoost Target$12.00 ➝ $18.00
7/21/2022Piper SandlerDowngradeOverweight ➝ Neutral
7/21/2022Canaccord Genuity GroupDowngradeBuy ➝ Hold
7/21/2022BarclaysDowngradeOverweight ➝ Equal Weight$15.00 ➝ $18.00
7/21/2022William BlairDowngradeOutperform ➝ Market Perform
7/12/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$11.00 ➝ $12.00
7/7/2022BTIG ResearchUpgradeNeutral ➝ Buy$15.00
5/26/2022Stifel NicolausInitiated CoverageBuy$12.00
5/24/2022Piper SandlerLower Target$20.00 ➝ $15.00
5/6/2022Deutsche Bank AktiengesellschaftLower Target$16.00 ➝ $11.00
5/5/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$18.00 ➝ $14.00
5/5/2022CitigroupLower Target$17.00 ➝ $14.00
3/29/2022GuggenheimInitiated CoverageNeutral
3/17/2022CitigroupLower Target$25.00 ➝ $17.00
3/10/2022William BlairReiterated RatingOutperform
2/25/2022Canaccord Genuity GroupLower Target$34.00 ➝ $18.00
2/25/2022Deutsche Bank AktiengesellschaftLower TargetBuy$18.00 ➝ $16.00
2/24/2022Morgan StanleyLower TargetOverweight$24.00 ➝ $14.00
2/24/2022Truist FinancialLower Target$24.00 ➝ $12.00
2/24/2022Piper SandlerLower TargetOverweight$37.00 ➝ $20.00
2/24/2022Leerink PartnersLower TargetMarket Perform$24.00 ➝ $10.00
2/24/2022KeyCorpLower TargetOverweight$30.00 ➝ $14.00
1/25/2022Deutsche Bank AktiengesellschaftLower Target$32.00 ➝ $18.00
12/21/2021JPMorgan Chase & Co.Lower TargetOverweight$41.00 ➝ $28.00
12/17/2021Morgan StanleyInitiated CoverageOverweight
12/15/2021Credit Suisse GroupLower TargetOutperform$39.00 ➝ $32.00
11/15/2021Deutsche Bank AktiengesellschaftLower TargetBuy$34.00 ➝ $32.00
11/9/2021Leerink PartnersBoost TargetMarket Perform$22.00 ➝ $24.00
11/4/2021KeyCorpLower TargetOverweight$38.00 ➝ $30.00
10/13/2021Truist FinancialLower TargetBuy$48.00 ➝ $28.00
10/7/2021CitigroupLower TargetBuy$46.00 ➝ $32.00
9/27/2021Leerink PartnersInitiated CoverageMarket Perform$22.00
9/24/2021Piper SandlerLower TargetOverweight$55.50 ➝ $37.00
8/12/2021BarclaysInitiated CoverageOverweight$32.00
8/9/2021Robert W. BairdDowngradeOutperform ➝ Neutral$43.00 ➝ $31.00
8/5/2021KeyCorpLower TargetOverweight$41.00 ➝ $38.00
8/5/2021Deutsche Bank AktiengesellschaftLower TargetNeutral ➝ Buy$39.00 ➝ $34.00
8/5/2021CitigroupBoost TargetBuy$46.00 ➝ $55.00
6/9/2021Deutsche Bank AktiengesellschaftLower TargetBuy$50.00 ➝ $39.00
5/27/2021Robert W. BairdInitiated CoverageOutperform$43.00
5/21/2021KeyCorpInitiated CoverageOverweight$41.00
5/17/2021Credit Suisse GroupLower TargetOutperform$56.00 ➝ $50.00
5/13/2021Truist FinancialLower TargetBuy ➝ Buy$56.00 ➝ $48.00
5/13/2021CitigroupLower TargetBuy ➝ Buy$61.00 ➝ $55.00
5/3/2021Jefferies Financial GroupInitiated CoverageBuy$63.00
3/15/2021Evercore ISIInitiated CoverageOutperform$48.00
3/1/2021Credit Suisse GroupBoost TargetOutperform$40.00 ➝ $56.00
3/1/2021Morgan StanleyBoost TargetOverweight$44.00 ➝ $50.00
2/26/2021Truist FinancialBoost Target$40.00 ➝ $56.00
2/26/2021Leerink PartnersLower TargetOutperform$55.00 ➝ $53.00
2/26/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$42.00 ➝ $53.00
2/4/2021CitigroupBoost Target$42.00 ➝ $62.00
1/29/2021Leerink PartnersUpgradeMarket Perform ➝ Outperform$38.00 ➝ $55.00
1/8/2021Piper SandlerBoost TargetOverweight$44.00 ➝ $51.00
1/6/2021BTIG ResearchInitiated CoverageNeutral
12/16/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$38.00 ➝ $42.00
11/11/2020Smith Barney CitigroupBoost Target$38.00 ➝ $42.00
11/11/2020JPMorgan Chase & Co.Reiterated RatingOverweight$40.00 ➝ $43.00
11/11/2020Credit Suisse GroupBoost TargetOutperform$37.00 ➝ $40.00
11/11/2020Piper SandlerBoost TargetOverweight$43.00 ➝ $44.00
11/11/2020Leerink PartnersBoost TargetMarket Perform$36.00 ➝ $38.00
11/11/2020Morgan StanleyBoost TargetOverweight$35.00 ➝ $41.00
10/30/2020Credit Suisse GroupInitiated CoverageOutperform$37.00
10/14/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$37.00
8/14/2020Truist FinancialBoost Target$30.00 ➝ $36.00
8/13/2020Wells Fargo & CompanyBoost TargetEqual Weight$23.00 ➝ $28.00
7/17/2020Piper SandlerBoost TargetOverweight$40.00 ➝ $43.00
7/8/2020CitigroupBoost TargetPositive ➝ Neutral$20.00 ➝ $38.00
7/1/2020Leerink PartnersInitiated CoverageMarket Perform$36.00
6/30/2020Piper SandlerBoost TargetOverweight$29.00 ➝ $40.00
5/18/2020Morgan StanleyBoost TargetOverweight$21.00 ➝ $35.00
5/14/2020SunTrust BanksBoost TargetBuy$26.00 ➝ $30.00
5/14/2020Piper SandlerReiterated RatingOverweight$27.00 ➝ $29.00
5/14/2020Wells Fargo & CompanyBoost TargetEqual Weight$18.00 ➝ $23.00
4/1/2020CitigroupLower TargetNeutral$25.00 ➝ $20.00
3/19/2020Morgan StanleyLower TargetOverweight$27.00 ➝ $21.00
2/25/2020Morgan StanleyInitiated CoverageOverweight$27.00
2/25/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$24.00
2/25/2020Robert W. BairdInitiated CoverageNeutral$24.00
2/25/2020JPMorgan Chase & Co.Initiated CoverageOverweight$28.00
2/25/2020SunTrust BanksInitiated CoverageBuy$30.00
2/25/2020CitigroupInitiated CoverageNeutral$25.00
2/25/2020William BlairInitiated CoverageOutperform
2/25/2020Piper SandlerInitiated CoverageOverweight$29.00
(Data available from 1/28/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/29/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/29/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/28/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
1Life Healthcare logo
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $16.47
Low: $16.47
High: $16.47

50 Day Range

MA: $16.09
Low: $14.97
High: $16.57

52 Week Range

Now: $16.47
Low: $5.94
High: $17.55

Volume

523,503 shs

Average Volume

3,216,415 shs

Market Capitalization

$3.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.99

Frequently Asked Questions

What sell-side analysts currently cover shares of 1Life Healthcare?

The following Wall Street sell-side analysts have issued research reports on 1Life Healthcare in the last year:
View the latest analyst ratings for ONEM.

What is the current price target for 1Life Healthcare?

0 Wall Street analysts have set twelve-month price targets for 1Life Healthcare in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for 1Life Healthcare in the next year.
View the latest price targets for ONEM.

What is the current consensus analyst rating for 1Life Healthcare?

1Life Healthcare currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ONEM.

What other companies compete with 1Life Healthcare?

Other companies that are similar to 1Life Healthcare include Hims & Hers Health, Teladoc Health, Auna, SBC Medical Group and AirSculpt Technologies. Learn More about companies similar to 1Life Healthcare.

How do I contact 1Life Healthcare's investor relations team?

1Life Healthcare's physical mailing address is One Embarcadero Center Suite 1900, San Francisco CA, 94111. The company's listed phone number is 415-814-0927 and its investor relations email address is [email protected]. The official website for 1Life Healthcare is www.onemedical.com. Learn More about contacing 1Life Healthcare investor relations.